MiR-124 Inhibits Growth and Enhances Radiation-Induced Apoptosis in Non-Small Cell Lung Cancer by Inhibiting STAT3

Mengjie Wang1,2, Bi Meng1,2, Yangchen Liu2

  • 1Bengbu Medical School, Bengbu, China.

Abstract

Insights

MicroRNA-124 (miR-124) is downregulated in non-small-cell lung carcinoma (NSCLC) and enhances radiosensitivity by targeting STAT3. Restoring miR-124 may improve radiation therapy for NSCLC patients.

Area of Science:

  • Molecular Biology
  • Oncology
  • Radiotherapy Research

Background:

  • MicroRNAs (miRNAs) are increasingly recognized for their role in cellular responses to ionizing radiation (IR).
  • Abnormal miRNA expression is implicated in cancer development and treatment resistance.
  • Non-small-cell lung carcinoma (NSCLC) radiosensitivity is a critical factor in treatment outcomes.

Purpose of the Study:

  • To investigate the correlation between miR-124 expression and radiosensitivity in NSCLC.
  • To elucidate the molecular mechanisms underlying miR-124's effect on NSCLC radiosensitivity.

Main Methods:

  • Quantitative reverse transcription polymerase chain reaction (RT-PCR) for miR-124 expression analysis.
  • Cell proliferation (CCK-8) and apoptosis assays (flow cytometry) to assess miR-124 function.
  • Luciferase activity, RT-PCR, and Western blot assays to identify and validate miR-124 targets.

Main Results:

  • miR-124 was significantly downregulated in NSCLC tissues and cell lines.
  • miR-124 suppressed NSCLC cell proliferation and promoted apoptosis following ionizing radiation exposure.
  • Signal transducer and activator of transcription 3 (STAT3) was identified as a direct target of miR-124.
  • STAT3 overexpression reversed the radiosensitizing effects of miR-124 in NSCLC cells.

Conclusions:

  • miR-124 plays a crucial role in regulating NSCLC radiosensitivity.
  • Targeting STAT3 by miR-124 offers a potential therapeutic strategy to enhance radiosensitivity in NSCLC.
  • miR-124 represents a promising biomarker and therapeutic target for improving radiation therapy efficacy in NSCLC.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.7K